Skip to content

Multiple Areas of Pain (MAP)

Multiple Areas of Pain (MAP): Epidemiology of Multisite Pain in the Chronic Pain Population

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01583894
Acronym
MAP
Enrollment
828
Registered
2012-04-24
Start date
2012-06-30
Completion date
2014-03-31
Last updated
2020-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Brief summary

This study will collect pain-related information from chronic pain patients to gain an understanding of the prevalence of multi-site pain, and how it affects health outcomes like function, quality of life, depression, and anxiety.

Interventions

None listed

Sponsors

Boston Scientific Corporation
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Chronic pain of the trunk and/or limbs lasting at least 6 months * Overall pain intensity of at least 5 on a 0 to 10 scale * Subject is able to independently complete all assessments in English * 18 years of age or older * Subject signs an Institutional Review Board-approved informed consent form provided in English Key

Exclusion criteria

* Currently implanted with an active implantable medical device to treat pain * Currently exhibits any characteristic that renders the subject ineligible for current or future treatment with spinal cord stimulation for chronic pain of the trunk and/or limbs * Subject has undergone an interventional pain procedure less than 1 month prior to the study

Design outcomes

Primary

MeasureTime frameDescription
Multi-site Pain Indexsingle-visitMultiple Site Pain Index (MSPI) was developed by collating multiple pain descriptors into a single index. Pain descriptors used for developing this index were percent body area in pain, number of painful areas, span of painful areas, and Regional Pain Ratings (RPRs) which includes data on pain severity and pain continuity for 47 body regions. MSPI score ranged from 0 to 1; 0 representing no pain and 1 representing extreme continuous pain over entire body, except the head and face regions.

Countries

United States

Participant flow

Participants by arm

ArmCount
Chronic Pain Patients
Patients suffering from chronic intractable pain of the trunk and/or limbs for a duration of at least 6 months
828
Total828

Baseline characteristics

CharacteristicChronic Pain Patients
Age, Continuous52.3 years
STANDARD_DEVIATION 13.23
Sex/Gender, Customized
Female
527 participants
Sex/Gender, Customized
Male
299 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Multi-site Pain Index

Multiple Site Pain Index (MSPI) was developed by collating multiple pain descriptors into a single index. Pain descriptors used for developing this index were percent body area in pain, number of painful areas, span of painful areas, and Regional Pain Ratings (RPRs) which includes data on pain severity and pain continuity for 47 body regions. MSPI score ranged from 0 to 1; 0 representing no pain and 1 representing extreme continuous pain over entire body, except the head and face regions.

Time frame: single-visit

Population: MSPI was calculated using multiple pain descriptors which were obtained from pain drawings. 810 of the 813 patients that completed the study provided complete pain drawing data, and so MSPI could be calculated only in 810 patients.

ArmMeasureValue (MEAN)Dispersion
Chronic Pain PatientsMulti-site Pain Index0.52 units on a scaleStandard Deviation 0.13

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026